Literature DB >> 17401518

Transcranial color-coded sonography helps differentiation between idiopathic Parkinson's disease and vascular parkinsonism.

Chung-Fen Tsai1, Ruey-Meei Wu, Yu-Weng Huang, Li-Ling Chen, Ping-Keung Yip, Jiann-Shing Jeng.   

Abstract

BACKGROUND: Recently, transcranial color-coded sonography (TCCS) has been found to have a diagnostic value in patients with idiopathic Parkinson's disease (IPD), which displays increased hyperechogenicity at the substantia nigra (SN).
OBJECTIVE: To use TCCS, to assess the difference in SN hyperechogenicity and intracranial hemodynamics among subjects with IPD, vascular parkinsonism (VP) and controls.
METHODS: Eighty IPD and 30 VP patients, and 60 controls were recruited into this study. The hyperechogenicity area at the SN and midbrain were calculated by encircling the outer circumference from the ipsilateral temporal window, using TCCS in each subject. The hemodynamics of intracranial large arteries, including flow velocity and pulsatility index (PI), were also measured.
RESULTS: The presence of SN hyperechogenicity was significantly higher in the IPD patients than in the VP patients and controls (84% vs. 20% &amp; 5%, respectively, p < 0.001). In IPD patients, the SN hyperechogenicity was correlated with the neurological severity and disease duration. Twenty-five (66.7%) VP patients had obvious vascular abnormality, as seen in TCCS study. The mean PI was significantly more elevated in the VP patients than those in the IPD patients and controls (all p < 0.05), but there was no significant difference of flow velocities among the VP, IPD patients and controls.
CONCLUSION: TCCS, combining B-mode imaging for SN echogenicity and trancranial Doppler for intracranial hemodynamics, is a useful diagnostic tool in the differentiation between IPD and VP. These findings also suggest that multiple subcortical vascular lesions may damage the basal ganglia and thalamocortical circuit and result in parkinsonism features in VP patients.

Entities:  

Mesh:

Year:  2007        PMID: 17401518     DOI: 10.1007/s00415-006-0403-9

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  29 in total

1.  Brain dopamine metabolism in patients with Parkinson's disease measured with positron emission tomography.

Authors:  K L Leenders; A J Palmer; N Quinn; J C Clark; G Firnau; E S Garnett; C Nahmias; T Jones; C D Marsden
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-08       Impact factor: 10.154

2.  Brain parenchyma sonography detects preclinical parkinsonism.

Authors:  Uwe Walter; Christine Klein; Ruediger Hilker; Reiner Benecke; Peter P Pramstaller; Dirk Dressler
Journal:  Mov Disord       Date:  2004-12       Impact factor: 10.338

3.  Prevalence of PD and other types of parkinsonism in three elderly populations of central Spain.

Authors:  Julián Benito-León; Félix Bermejo-Pareja; Javier Rodríguez; José-Antonio Molina; Rafael Gabriel; José-Manuel Morales
Journal:  Mov Disord       Date:  2003-03       Impact factor: 10.338

4.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

5.  Vascular parkinsonism: a distinct, heterogeneous clinical entity.

Authors:  M Demirkiran; H Bozdemir; Y Sarica
Journal:  Acta Neurol Scand       Date:  2001-08       Impact factor: 3.209

6.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

7.  Differential diagnosis of Parkinson's disease and vascular parkinsonism by (99m)Tc-TRODAT-1.

Authors:  K Y Tzen; C S Lu; T C Yen; S P Wey; G Ting
Journal:  J Nucl Med       Date:  2001-03       Impact factor: 10.057

8.  Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease.

Authors:  D T Dexter; F R Wells; A J Lees; F Agid; Y Agid; P Jenner; C D Marsden
Journal:  J Neurochem       Date:  1989-06       Impact factor: 5.372

9.  Striatal dopamine distribution in parkinsonian patients during life.

Authors:  C Nahmias; E S Garnett; G Firnau; A Lang
Journal:  J Neurol Sci       Date:  1985-07       Impact factor: 3.181

10.  Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain.

Authors:  E Sofic; P Riederer; H Heinsen; H Beckmann; G P Reynolds; G Hebenstreit; M B Youdim
Journal:  J Neural Transm       Date:  1988       Impact factor: 3.575

View more
  15 in total

Review 1.  Substantia nigra hyperechogenicity is a risk marker of Parkinson's disease: no.

Authors:  Uwe Walter
Journal:  J Neural Transm (Vienna)       Date:  2010-12-29       Impact factor: 3.575

Review 2.  Developments in the role of transcranial sonography for the differential diagnosis of parkinsonism.

Authors:  Andrea Pilotto; Rezzak Yilmaz; Daniela Berg
Journal:  Curr Neurol Neurosci Rep       Date:  2015-07       Impact factor: 5.081

3.  Plasma ceruloplasmin ferroxidase activity correlates with the nigral sonographic area in Parkinson's disease patients: a pilot study.

Authors:  Rubén Martínez-Hernández; Sergio Montes; Jesus Higuera-Calleja; Petra Yescas; Marie-Catherine Boll; Araceli Diaz-Ruiz; Camilo Rios
Journal:  Neurochem Res       Date:  2011-06-26       Impact factor: 3.996

Review 4.  Substantia nigra hyperechogenicity is a risk marker of Parkinson's disease: yes.

Authors:  Daniela Berg
Journal:  J Neural Transm (Vienna)       Date:  2011-01-05       Impact factor: 3.575

5.  Hand function is impaired in healthy older adults at risk of Parkinson's disease.

Authors:  Gabrielle Todd; Miranda Haberfield; Patrick L Faulkner; Caroline Rae; Michael Hayes; Robert A Wilcox; Janet L Taylor; Simon C Gandevia; Jana Godau; Daniela Berg; Olivier Piguet; Kay L Double
Journal:  J Neural Transm (Vienna)       Date:  2014-05-03       Impact factor: 3.575

Review 6.  Hyperechogenicity of the substantia nigra: pitfalls in assessment and specificity for Parkinson's disease.

Authors:  Daniela Berg
Journal:  J Neural Transm (Vienna)       Date:  2010-09-10       Impact factor: 3.575

7.  Parkinsonism in a pair of monozygotic CADASIL twins sharing the R1006C mutation: a transcranial sonography study.

Authors:  Michele Ragno; Sandro Sanguigni; Antonio Manca; Luigi Pianese; Cristina Paci; Alfonso Berbellini; Valeria Cozzolino; Roberto Gobbato; Silvio Peluso; Giuseppe De Michele
Journal:  Neurol Sci       Date:  2016-02-05       Impact factor: 3.307

Review 8.  Transcranial duplex in the differential diagnosis of parkinsonian syndromes: a systematic review.

Authors:  Annemarie M M Vlaar; Angela Bouwmans; Werner H Mess; Selma C Tromp; Wim E J Weber
Journal:  J Neurol       Date:  2009-02-17       Impact factor: 4.849

Review 9.  Role of iron in neurodegenerative diseases.

Authors:  Kai Li; Heinz Reichmann
Journal:  J Neural Transm (Vienna)       Date:  2016-01-21       Impact factor: 3.575

10.  Illicit stimulant use is associated with abnormal substantia nigra morphology in humans.

Authors:  Gabrielle Todd; Carolyn Noyes; Stanley C Flavel; Chris B Della Vedova; Peter Spyropoulos; Barry Chatterton; Daniela Berg; Jason M White
Journal:  PLoS One       Date:  2013-02-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.